CCI Wants Governments to Buy More Canadian Healthtech

Why It Matters

Adopting these measures could unlock billions in efficiency gains and strengthen Canada’s domestic health‑tech ecosystem, reducing reliance on foreign solutions. The changes would also improve patient care continuity across provinces.

Key Takeaways

• CCI recommends healthtech Buy Canadian procurement policy.
• Value-based procurement to replace lowest‑bidder model.
• Adopt HL7 FHIR standard for national data interoperability.
• Enable shared RFPs to reduce duplicate vetting.
• Provide de‑identified health datasets for AI development.

Pulse Analysis

Canada’s fragmented health‑tech procurement landscape hampers innovation and drives up costs. Most provinces still award contracts to the lowest bidder, ignoring factors such as interoperability, total cost of ownership, and security. CCI’s report highlights how a coordinated, value‑based purchasing framework—mirroring the recent Defence Industrial Strategy—could streamline acquisitions, foster competition among domestic vendors, and ensure that public funds nurture home‑grown solutions rather than subsidising foreign platforms.

Interoperability sits at the heart of the efficiency argument. Studies by Canada Health Infoway estimate that better data exchange could free up $2.4 billion annually by eliminating redundant searches and manual data entry. By mandating the HL7 Fast Healthcare Interoperability Resources (FHIR) standard and allowing provinces to piggy‑back on existing RFPs, the government can accelerate the rollout of unified electronic health records. Such a move not only cuts procurement overhead but also creates a scalable foundation for emerging technologies like AI‑driven clinical assistants.

The push for domestic data assets raises privacy and governance concerns. While de‑identified, aggregated datasets are essential for training AI models, safeguards must align with provincial privacy laws and recent high‑profile breaches. CCI’s recommendation to establish clear data‑portability standards and secure sharing protocols aims to balance innovation with patient trust. If implemented, these policies could position Canada as a leader in responsible health‑tech development, delivering faster, more reliable care while protecting sensitive information.